◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cardiol Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 5.4M 4.9M 4.6M 5.8M 10.2M --
General And Administrative Expense 5.4M 4.9M 4.6M 5.8M 10.2M --
Research And Development 4.8M 2.7M 3.8M 4.2M 3.8M --
Depreciation And Amortization In Income Statement 25,551 25,470 24,986 -- 201,090 61,908
Operating Expense 10.2M 7.7M 8.4M 10.0M 14.1M --
Operating Income -10.2M -7.7M -8.4M -10.0M -14.1M --
EBIT -10.2M -7.7M -8.4M -10.0M -14.1M --
Interest Income 122,256 180,667 248,269 306,775 201,864 --
Interest Income Non Operating 122,256 180,667 248,269 306,775 201,864 --
Net Interest Income 122,256 180,667 248,269 306,775 201,864 --
Other Income Expense 93,563 -858,880 -106,859 1.5M 1.2M --
Other Non Operating Income Expenses -- -- -- 0.00 -- --
Gain On Sale Of Security 93,563 -858,880 -106,859 1.5M 1.2M --
Pretax Income -10.0M -8.4M -8.3M -8.2M -12.7M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Income From Continuing Operation Net Minority Interest -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Income Including Noncontrolling Interests -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Income Common Stockholders -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Income -10.0M -8.4M -8.3M -8.2M -12.7M --
EBITDA -10.2M -7.7M -8.4M -9.9M -13.9M --
Normalized EBITDA -10.2M -6.8M -8.3M -11.4M -15.1M --
Reconciled Depreciation 25,551 25,470 24,986 48,493 201,090 --
Basic EPS -0.12 -0.10 -0.10 -- -0.18 -0.10
Diluted EPS -0.12 -0.10 -0.10 -- -0.18 -0.10
Basic Average Shares 84.7M 82.7M 82.6M -- 69.8M 68.8M
Diluted Average Shares 84.7M 82.7M 82.6M -- 69.8M 68.8M
Total Unusual Items 93,563 -858,880 -106,859 1.5M 1.2M --
Total Unusual Items Excluding Goodwill 93,563 -858,880 -106,859 1.5M 1.2M --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -10.1M -7.5M -8.2M -9.7M -13.9M --
Amortization 0.00 0.00 0.00 -- 168,136 21,111
Amortization Of Intangibles Income Statement 0.00 0.00 0.00 -- 168,136 21,111
Depreciation Amortization Depletion Income Statement 25,551 25,470 24,986 -- 201,090 61,908
Depreciation Income Statement 25,551 25,470 24,986 -- 32,954 40,797
Diluted NI Availto Com Stockholders -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Income Continuous Operations -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Non Operating Interest Income Expense 122,256 180,667 248,269 306,775 201,864 --
Other Gand A 2.1M 2.7M 3.8M 5.8M 2.7M --
Salaries And Wages 3.3M 2.2M 838,346 -- 7.4M 1.8M
Total Expenses 10.2M 7.7M 8.4M 10.0M 14.1M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 11.6M 18.2M 23.3M 30.6M 15.9M --
Cash Cash Equivalents And Short Term Investments 11.6M 18.2M 23.3M 30.6M 15.9M --
Accounts Receivable 37,494 58,921 75,960 100,366 57,079 --
Receivables 195,880 279,887 346,690 361,621 266,706 --
Prepaid Assets 988,532 1.3M 1.6M 726,509 1.1M --
Current Assets 12.8M 19.8M 25.3M 31.7M 17.3M --
Gross PPE 989,647 986,629 980,190 968,251 1.0M --
Accumulated Depreciation -848,666 -823,115 -797,645 -772,659 -771,021 --
Net PPE 140,981 163,514 182,545 195,592 237,926 --
Goodwill And Other Intangible Assets -- -- -- 0.00 0.00 168,136
Other Intangible Assets -- -- -- -- -- 168,136
Total Non Current Assets 140,981 163,514 182,545 195,592 237,926 --
Total Assets 12.9M 19.9M 25.5M 31.9M 17.5M --
Current Debt And Capital Lease Obligation 36,925 35,556 34,252 33,009 31,785 --
Payables And Accrued Expenses 3.3M 8.0M 7.7M 7.0M 6.9M --
Other Current Liabilities -- -- -- -- 3,647 1.4M
Current Liabilities 3.3M 8.0M 7.8M 7.0M 7.0M --
Long Term Debt And Capital Lease Obligation 97,274 106,998 116,408 125,523 134,199 --
Long Term Capital Lease Obligation 97,274 106,998 116,408 125,523 134,199 --
Total Non Current Liabilities Net Minority Interest 97,274 106,998 116,408 125,523 134,199 --
Total Liabilities Net Minority Interest 3.4M 8.1M 7.9M 7.1M 7.1M --
Common Stock 187.4M 179.5M 179.3M 179.3M 154.6M --
Capital Stock 187.4M 179.5M 179.3M 179.3M 154.6M --
Additional Paid In Capital 28.1M 28.2M 25.8M 24.6M 27.5M --
Retained Earnings -205.9M -195.9M -187.5M -179.3M -171.7M --
Common Stock Equity 9.6M 11.8M 17.6M 24.7M 10.4M --
Stockholders Equity 9.6M 11.8M 17.6M 24.7M 10.4M --
Total Equity Gross Minority Interest 9.6M 11.8M 17.6M 24.7M 10.4M --
Total Capitalization 9.6M 11.8M 17.6M 24.7M 10.4M --
Net Tangible Assets 9.6M 11.8M 17.6M 24.7M 10.4M --
Tangible Book Value 9.6M 11.8M 17.6M 24.7M 10.4M --
Working Capital 9.5M 11.8M 17.5M 24.7M 10.3M --
Invested Capital 9.6M 11.8M 17.6M 24.7M 10.4M --
Total Debt 134,199 142,554 150,660 158,532 165,984 --
Share Issued 87.5M 82.7M 82.6M 82.6M 70.2M --
Ordinary Shares Number 87.5M 82.7M 82.6M 82.6M 70.2M --
Capital Lease Obligations 134,199 142,554 150,660 158,532 165,984 --
Current Capital Lease Obligation 36,925 35,556 34,252 33,009 31,785 --
Leases 237,248 237,248 237,248 237,248 237,248 --
Machinery Furniture Equipment 238,207 235,189 228,750 216,811 210,652 --
Other Properties 514,192 514,192 514,192 514,192 561,047 --
Other Receivables 158,386 220,966 270,730 261,255 209,627 --
Properties 0.00 0.00 0.00 0.00 0.00 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -6.9M -4.6M -7.2M -5.6M -7.8M --
Cash Flow From Continuing Operating Activities -6.9M -4.6M -7.2M -5.6M -7.8M --
Depreciation And Amortization 25,551 25,470 24,986 48,493 201,090 --
Depreciation Amortization Depletion 25,551 25,470 24,986 48,493 201,090 --
Stock Based Compensation 4.0M 2.5M 1.1M 3.1M 8.4M --
Change In Working Capital -622,146 671,355 -151,824 990,411 -2.7M --
Changes In Account Receivables 21,427 17,039 24,406 -43,287 36,572 --
Change In Receivables 84,007 66,803 14,931 -94,915 -24,282 --
Change In Payables And Accrued Expense -1.0M 270,839 739,695 681,840 -3.1M --
Other Non Cash Items 5,489 5,738 5,972 6,392 6,326 --
Capital Expenditure -3,018 -6,439 -11,939 -6,159 -7,871 --
Purchase Of PPE -3,018 -6,439 -11,939 -6,159 -7,871 --
Net PPE Purchase And Sale -3,018 -6,439 -11,939 -6,159 -7,871 --
Investing Cash Flow -3,018 -6,439 -11,939 -6,159 -7,871 --
Cash Flow From Continuing Investing Activities -3,018 -6,439 -11,939 -6,159 -7,871 --
Repayment Of Debt -13,844 -13,844 -13,844 -13,844 -4,615 --
Net Issuance Payments Of Debt -13,844 -13,844 -13,844 -13,844 -4,615 --
Financing Cash Flow -13,844 20,416 -13,844 18.7M -4,615 --
Cash Flow From Continuing Financing Activities -13,844 20,416 -13,844 18.7M -4,615 --
Effect Of Exchange Rate Changes 369,229 -561,052 -107,778 1.6M -354,655 --
Changes In Cash -6.9M -4.5M -7.2M 13.1M -7.8M --
Beginning Cash Position 18.2M 23.3M 30.6M 15.9M 24.0M --
End Cash Position 11.6M 18.2M 23.3M 30.6M 15.9M --
Free Cash Flow -6.9M -4.6M -7.2M -5.6M -7.8M --
Amortization Cash Flow 0.00 0.00 0.00 0.00 168,136 --
Amortization Of Intangibles 0.00 0.00 0.00 0.00 168,136 --
Change In Prepaid Assets 310,714 333,713 -906,450 403,486 487,859 --
Depreciation 25,551 25,470 24,986 48,493 32,954 --
Gain Loss On Investment Securities -- -- -- -3,647 -1.4M -691,047
Long Term Debt Payments -13,844 -13,844 -13,844 -13,844 -4,615 --
Net Foreign Currency Exchange Gain Loss -369,229 561,052 107,778 -1.6M 354,655 --
Net Income From Continuing Operations -10.0M -8.4M -8.3M -8.2M -12.7M --
Net Long Term Debt Issuance -13,844 -13,844 -13,844 -13,844 -4,615 --
Operating Gains Losses -369,229 561,052 107,778 -1.6M -997,430 --
Proceeds From Stock Option Exercised 0.00 34,260 0.00 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...